NodeAI solves a critical problem in the lung cancer diagnostic journey. Patients who are diagnosed with lung cancer will undergo a test (EBUS-TBNA), whose results will determine the next step in treatment. NodeAI has developed an AI-augmented software platform that increases the accuracy of EBUS-TBNA from ~55% to 82%, delivering results in 6 seconds—turning what once took weeks into near-instantaneous insights. The system is both precise and simple, designed to be device and user agnostic, dramatically increasing access for patients who need it most.